Abstract Search

ea0041ep1053 | Thyroid (non-cancer) | ECE2016

Can routine steroid cover during radioiodine therapy of patients with Graves’ disease (GD) prevent the onset of de novo Graves’ orbitopathy (GO)?

Kowalska Aldona , Palyga Iwona , Gasior-Perczak Danuta , Mikina Estera , Szymonek Monika , Piwowar Monika , Gadawska-Juszczyk Klaudia , Trybek Tomasz , Mezyk Ryszard , Gozdz Stanislaw

Introduction: Radioiodine therapy is considered as a risk factor for the development of Graves orbitopathy (GO) de novo or worsening of pre-existing orbitopathy. This risk is estimated in the available literature as up to 1520%. Steroid cover is considered to eliminated this risk.Objective: The aim of our study was to established the relationship between the occurrence of GO and treatment with radioiodine. And the analysis of the time of appe...

0 shares

ePoster

ea0049ep1274 | Thyroid (non-cancer) | ECE2017

Is there a correlation between serum selenium level and the severity of Graves’ orbitopathy?

Palyga Iwona , Gasior-Perczak Danuta , Gadawska-Juszczyk Klaudia , Mikina Estera , Piwowar Monika , Szymonek Monika , Trybek Tomasz , Walczyk Agnieszka , Mezyk Ryszard , Majewska Urszula , Kowalska Aldona

Introduction: Selenium (Se) deficiency is a known risk factor for autoimmune thyroid diseases including Graves orbitopathy (GO).Objective: To determine the concentration of Se in serum and to determine the dependency of Se concentration on known markers of disease severity: the TRAB levels and the CAS (clinical activity score) in patients with GO.Material: 64 patients (50 women, 14 men; average age- 54.5 years) with active, m...

0 shares

Endocrine Abstracts

Can routine steroid cover during radioiodine therapy of patients with Graves’ disease (GD) prevent the onset of de novo Graves’ orbitopathy (GO)?

Is there a correlation between serum selenium level and the severity of Graves’ orbitopathy?

BiosciAbstracts